NAVER Corporation has announced a donation of 30 billion KRW over a span of three years to Seoul National University Hospital in South Korea to support research in the digital bio field. This represents the largest single donation ever received for research funding at the hospital.

Through this funding, NAVER aims to make a significant impact by supporting innovative and challenging digital bio research at Seoul National University Hospital, contributing to the cultivation of medical scientists and the development of future medical advancements.

The hospital plans to utilise the donated funds to foster an environment where researchers can fully engage in their studies and effectively manage their research outcomes, thus establishing a research-oriented culture within the hospital.

NAVER’s CEO Choi Soo-Yeon stated "Through continuous support and collaboration, we aim to contribute to the development of digital bio talents and the growth of the industry."

 Kim Young-Tae, President & CEO of Seoul National University Hospital said "As a central national hospital, Seoul National University Hospital will concentrate its support on challenging and creative research as well as research projects that can lead to commercialisation, spearheading digital bio health, and establishing the benchmark for K-Digital healthcare.”